An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet. Inadvertent exposure to gluten can be a frequent occurrence for celiac patients that triggers symptoms, such as pain in the gut and diarrhea, due to intestinal damage.
Source: Experimental drug eases effects of gluten for celiac patients on gluten-free diet: First proof-of-concept study shows AMG 714 (anti-IL-15 monoclonal antibody) potentially protects celiac patients from inadvertent gluten exposure — ScienceDaily
Researchers have successfully treated patients whose obesity is caused by a genetic defect. Aside from its beneficial effects on the patients, the researchers also provided insights into the fundamental signaling pathways regulating satiety of the new drug.
Source: Switching off insatiable hunger: A new drug to help young patients with genetic obesity — ScienceDaily
A drug used to slow cognitive decline in Alzheimer’s disease could offer clues on how drugs might one day be able to reverse brain changes that affect learning and memory in teens and young adults who binge drink.
Source: Alzheimer’s drug repairs brain damage after alcohol binges in rodents: Drug appears to reverse structural and genetic brain changes that affect memory, learning — ScienceDaily